ED
BTAQ

Exane Derivatives’s Burgundy Technology Acquisition Corporation Class A Ordinary shares BTAQ Stock Holding History

Exane Derivatives’s Portfolio BTAQ Stock Details BTAQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-47,000
Closed -$464K – 1090
2021
Q2 		$464K Hold
47,000
– – 0.11% 197
2021
Q1 		$465K Buy
+47,000
New +$499K 0.13% 158

Other funds holding BTAQ

CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return

Exane Derivatives's BTAQ Position: Q3 2021 in Review

Exane Derivatives sold out of Burgundy Technology Acquisition Corporation Class A Ordinary shares (BTAQ) in Q3 2021, closing a stake of 47,000 shares — an estimated $464K sold.

Exane Derivatives first reported a position in BTAQ in Q1 2021 and held it in 2 quarters. The position peaked at $465K in Q1 2021. 69 funds tracked by Wall St. Rank hold BTAQ as of Q3 2021.

  • Exane Derivatives reported no remaining Burgundy Technology Acquisition Corporation Class A Ordinary shares position as of Q3 2021 after selling out during the quarter.
  • Exane Derivatives sold 47,000 Burgundy Technology Acquisition Corporation Class A Ordinary shares shares in Q3 2021, an estimated $464K.
  • Exane Derivatives first reported a position in Burgundy Technology Acquisition Corporation Class A Ordinary shares in Q1 2021 and held it in 2 quarters.
  • Exane Derivatives's Burgundy Technology Acquisition Corporation Class A Ordinary shares position peaked at $465K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Burgundy Technology Acquisition Corporation Class A Ordinary shares as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.